| Study |
N of patients |
Stimulation parameters |
N of pulses / session |
N of sessions |
Outcome measure |
| Boylan et al., [54] |
10 |
10 Hz – 96% MT |
2000 |
1 |
UPDRS-III |
| Koch et al., [55] |
8 |
1 / 5 Hz – 90 / 110% RMT |
900 |
1 |
UPDRS-III |
| Brusa et al., [56] |
10 |
1 Hz – 90% RMT |
900 |
5 |
UPDRS-III |
| Hamada et al., [57] |
99 |
5 Hz – 110% RMT |
1000 |
8 |
UPDRS-III |
| Shirota et al., [58] |
106 |
1/ 10 Hz – 110% RMT |
1000 |
8 |
UPDRS-III |
| Sayin et al., [59] |
17 |
1 Hz – 90% RMT |
1800 |
10 |
UPDRS-III; AIMS |
|
| Table 2: rTMS studies in PD: SMA as target area. rTMS, repetitive Transcranial Magnetic Stimulation; PD, Parkinson’s Disease; SMA, Supplementary Motor Area; Hz, Hertz; RMT, resting motor threshold; MT, Motor Threshold; UPDRS (III), Unified Parkinson’s Disease Rating Scale (Section III); AIMS, Abnormal Involuntary Movement Scale. |
